Magnum Pharma And Diagnostic Services Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 23-10-2024
- Paid Up Capital ₹ 0.10 M
as on 23-10-2024
- Company Age 10 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 11.00 Cr
as on 23-10-2024
- Revenue 17.38%
(FY 2023)
- Profit -95.53%
(FY 2023)
- Ebitda 63.40%
(FY 2023)
- Net Worth 0.52%
(FY 2023)
- Total Assets 46.52%
(FY 2023)
About Magnum Pharma And Diagnostic Services
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹11.00 Cr.
Rashmi Chopda, Alkesh Chopda, and Sonali Chopda serve as directors at the Company.
- CIN/LLPIN
U24232MH2014PTC254557
- Company No.
254557
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Mar 2014
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Nashik, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Magnum Pharma And Diagnostic Services Private Limited offer?
Magnum Pharma And Diagnostic Services Private Limited offers a wide range of products and services, including ICU Equipments, Intensive Care Unit, Medical Surgery & Treatment Centres, Medical Treatment Services, Cardiology Treatment.
Who are the key members and board of directors at Magnum Pharma And Diagnostic Services?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sonali Chopda  | Director | 18-Mar-2014 | Current |
| Rashmi Chopda | Director | 18-Mar-2014 | Current |
| Alkesh Chopda | Director | 18-Mar-2014 | Current |
Financial Performance of Magnum Pharma And Diagnostic Services.
Magnum Pharma And Diagnostic Services Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 17.38% increase. The company also saw a substantial fall in profitability, with a 95.53% decrease in profit. The company's net worth moved up by a moderate rise of 0.52%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Magnum Pharma And Diagnostic Services?
In 2023, Magnum Pharma And Diagnostic Services had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Medezzy Pharmacy Private LimitedActive 4 years 2 monthsRashmi Chopda, Alkesh Chopda and 1 more are mutual person
Chopda Medicare And Research Centre Private LimitedActive 29 years 10 monthsRashmi Chopda is a mutual person
- Eternal Lifesciences Private LimitedActive 4 years 5 months
Alkesh Chopda and Sonali Chopda are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 02 Apr 2024 | ₹2.00 Cr | Open |
Others Creation Date: 12 Dec 2023 | ₹9.00 Cr | Open |
How Many Employees Work at Magnum Pharma And Diagnostic Services?
Unlock and access historical data on people associated with Magnum Pharma And Diagnostic Services, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Magnum Pharma And Diagnostic Services, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Magnum Pharma And Diagnostic Services's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
